🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

California to not do business with Walgreens over abortion pills issue- Governor

Published 03/06/2023, 02:55 PM
Updated 03/07/2023, 12:50 AM
© Reuters. FILE PHOTO: People walk by a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly
WBA
-

(Reuters) -California will not do business with Walgreens Boots Alliance (NASDAQ:WBA) Inc, state Governor Gavin Newsom said in a tweet on Monday, days after the pharmacy chain said it would not dispense abortion pills in some Republican-dominated states.

The state refuses to do business with Walgreens or "any company that cowers to the extremists and puts women's lives at risk," said Newsom, a Democrat.

A spokesperson for the governor said "all relationships" between Walgreens and the state were now under review but declined to detail how business ties might change.

Walgreens said last week it would not dispense abortion pills in 20 states, including states where abortion remains legal, where the Republican attorneys general have warned it of risking breaking the law if it distributed the pills.

In a statement issued later on Monday to clarify its position, Walgreens said it planned to dispense abortion pill mifepristone in any jurisdiction where it was legally permissible to do so.

"Once we are certified by FDA, we will dispense this medication consistent with federal and state laws", the company said.

© Reuters. FILE PHOTO: People walk by a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly

Walgreens did not immediately respond to a Reuters request to clarify whether it would dispense abortion pills in the 20 states where it was warned by Republican attorneys general.

The U.S. Food and Drug Administration in January allowed retail pharmacies to sell abortion pill mifepristone, including by mail, provided they were certified under special safety rules for the drug.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.